PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
April 15, 2024 at 08:14 am EDT
Share
PetMed Express, Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was USD 65.32 million compared to USD 58.87 million a year ago. Net loss was USD 2.03 million compared to USD 0.212 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to USD 0.01 a year ago.
For the nine months, sales was USD 214.56 million compared to USD 194.17 million a year ago. Net loss was USD 2.45 million compared to net income of USD 5.36 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to basic earnings per share from continuing operations of USD 0.26 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to diluted earnings per share from continuing operations of USD 0.26 a year ago.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.